The AimlBox Headlines #2: January 6, 2021

AimlBox Headlines is a bi-weekly 1 min.-read newsletter covering up-to-date developments in machine learning and artificial intelligence to help build your domain knowledge and expertise.

On this episode

  1. Cognizant acquires UK-based Artificial Intelligence and Machine Learning company Inawisdom

  2. Global Machine Learning Artificial intelligence Market 2025 To Expect Maximum Benefit and Growth Potential During this COVID 19 Outbreak

  3. Using artificial intelligence to find new uses for existing medications

  4. Computer Models Select the Best Public Health Interventions for COVID-19

If you are finding valuable information in this newsletter, please subscribe to a paid plan to support us and to start receiving our premium newsletters: The AimlBox Education, The AimlBox Entertainment

Industrial AI

Cognizant acquires UK-based Artificial Intelligence and Machine Learning company Inawisdom

Cognizant is acquiring UK-based AI company Inawisdom to expand its capabilities for global clients in the area of machine intelligence, cloud and IoT. Read the full story…

Global Machine Learning Artificial intelligence Market 2025 To Expect Maximum Benefit and Growth Potential During this COVID 19 Outbreak

Global Machine Learning Artificial intelligence Market report presented has been documented and mindfully articulated after ensuring thorough references of corporate websites, international journals, survey reports, besides engaging in detailed discussions and telephonic conversations with various stakeholders as well as company spokespersons, offering real-time on-field picture. Top companies to seamlessly entry into this growth trajectory: AIBrain, Amazon, Anki, Cloudminds, Google, and Deepmind. And segmentation by region: North America, Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS), Asia Pacific, Latin America, Middle East and Africa. See the entire report…

AI Research

Using artificial intelligence to find new uses for existing medications

Ping Zhang et al. have recently shown how deep learning algorithms can be applied to solve a fascinating problem - “how to repurpose existing drugs to diseases for which they are not prescribed.” Such a pursuit will reduce the risk associated with testing new medications and drastically reduce the time it takes to get a drug to the marketplace for clinical use. Read the full story at…

Computer Models Select the Best Public Health Interventions for COVID-19

The XPrize challenges simulators have introduced a $500,000 Pandemic Response Challenge to best predict the continuing global spread of COVID-19 and also to prescribe policies like closing schools and businesses to curtail it. Find out more about it…

Listen to AI Celebs

Editors’ Pick

Share